Sarepta Therapeutics Market Cap

Sarepta Therapeutics has a market cap or net worth of $3.85 billion as of June 5, 2025. Its market cap has decreased by -68.84% in one year.

Market Cap

3.85B

Enterprise Value

4.69B

1-Year Change

-68.84%

Ranking

#1467

Market Cap Chart

Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $3.85B, an increase of 6,498.36%. That is a compound annual growth rate of 17.11%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	3.85B	-66.82%
Dec 31, 2024	11.61B	28.75%
Dec 29, 2023	9.02B	-20.70%
Dec 30, 2022	11.37B	45.06%
Dec 31, 2021	7.84B	-41.72%
Dec 31, 2020	13.45B	39.87%
Dec 31, 2019	9.62B	31.90%
Dec 31, 2018	7.29B	102.79%
Dec 29, 2017	3.60B	140.16%
Dec 30, 2016	1.50B	-14.27%
Dec 31, 2015	1.75B	192.17%
Dec 31, 2014	597.80M	-21.92%
Dec 31, 2013	765.60M	16.58%
Dec 31, 2012	656.70M	549.55%
Dec 30, 2011	101.10M	-57.54%
Dec 31, 2010	238.10M	47.70%
Dec 31, 2009	161.20M	244.44%
Dec 31, 2008	46.80M	-38.26%
Dec 31, 2007	75.80M	-54.99%
Dec 29, 2006	168.40M	10.50%
Dec 30, 2005	152.40M	79.51%
Dec 31, 2004	84.90M	-33.15%
Dec 31, 2003	127.00M	-3.93%
Dec 31, 2002	132.20M	-47.73%
Dec 31, 2001	252.90M	148.18%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	674.20B
Johnson & Johnson	372.41B
AbbVie	330.07B
Novo Nordisk	323.14B
UnitedHealth Group	274.90B
Abbott Laboratories	230.23B
Novartis AG	228.01B
AstraZeneca	222.18B

Market Cap Rankings